Обзорная информация по основным характеристикам оригинальной топической формы диклофенака диэтиламина 1,16%
Обзорная информация по основным характеристикам оригинальной топической формы диклофенака диэтиламина 1,16%
G.Fotopoulos. Обзорная информация по основным характеристикам оригинальной топической формы диклофенака диэтиламина 1,16%. Справочник поликлинического врача. 2010; 4: 14–16.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Список литературы
1. Doogan PD. Topical non-steroidal anti-inflammatory drugs. Lancet 1989; 8674: 1270–1.
2. Singh P and Roberts MS. Skin permeability and local tissue concentrations of non-steroidal anti-inflammatory drugs after topical application. J Pharm Exp Ther 1994; 268: 144–51.
3. Muller M, Mascher H, Kikuta C et al. Diclofenac concentrations in defined tissue layers after topical administration. Clin Pharmacol Ther 1997; 62 (3): 293–9.
4. Higaki K, Nakayama K, Suyama T et al. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin. Int J Pharm 2005; 288 (2): 227–33.
5. Dreiser RL. Topical antirheumatic drug therapy: current practice and future trends. Eur J Rheumatol Inflamm 1994; 14 (4): 3–8.
6. Sioufi A, Pommier F, Boschet F et al. Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac Emulgel. Biopharm Drug Dispos 1994; 15 (6): 441–9.
7. Riess W, Schmid K, Botta L et al. The percutaneous absorption of diclofenac]. Arzneimittelforschung 1986; 36 (7): 1092–6.
8. Davies NM, Anderson KE. Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet 1997; 33 (3): 184–213.
9. Radermacher J, Jentsch D, Scholl MA et al. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 1991; 31 (5): 537–41.
10. Niethard FU, Gold MS, Solomon GS et al. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J Rheumatol 2005; 32 (12): 2384–92.
11. Zacher J, Burger KJ, Farber L et al. Topical diclofenac Emulgel versus oral ibuprofen in the treatment of active osteoarthritis of the finger joints (Heberden's and/or Bouchard's nodes). Double-blind, controlled, randomized study. Akt Rheumatol 2001; 26: 7–14.
12. Garcia Miranda R. Treatment of musculoskeletal injuries in athletes with a new topical antiphlogistic: Diethylammonium diclofenac. Double-blind comparative study. Compend.Invest.Clin.Latinoamer (MEX) 1987; 3: 9–24.
13. Diebschlag W. Diclofenac bei stumpf-traumatischen Sprunggelenkschwellungen. Fortschritte der Medizin 1986; 104: 437–440.
14. Magnette J, Kienzler JL, Alekxandrova I et al. The efficacy and safety of lowdose diclofenac sodium 0.1% gel for the symptomatic relief of pain and erythema associated with superficial natural sunburn. Eur J Dermatol 2004; 14 (4): 238–46.
15. Kienzler JL, Magnette J, Queille-Roussel C et al. Diclofenac-Na gel is effective in reducing the pain and inflammation associated with exposure to ultraviolet light – results of two clinical studies. Skin Pharmacol Physiol 2005; 18 (3): 144–52.
2. Singh P and Roberts MS. Skin permeability and local tissue concentrations of non-steroidal anti-inflammatory drugs after topical application. J Pharm Exp Ther 1994; 268: 144–51.
3. Muller M, Mascher H, Kikuta C et al. Diclofenac concentrations in defined tissue layers after topical administration. Clin Pharmacol Ther 1997; 62 (3): 293–9.
4. Higaki K, Nakayama K, Suyama T et al. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin. Int J Pharm 2005; 288 (2): 227–33.
5. Dreiser RL. Topical antirheumatic drug therapy: current practice and future trends. Eur J Rheumatol Inflamm 1994; 14 (4): 3–8.
6. Sioufi A, Pommier F, Boschet F et al. Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac Emulgel. Biopharm Drug Dispos 1994; 15 (6): 441–9.
7. Riess W, Schmid K, Botta L et al. The percutaneous absorption of diclofenac]. Arzneimittelforschung 1986; 36 (7): 1092–6.
8. Davies NM, Anderson KE. Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet 1997; 33 (3): 184–213.
9. Radermacher J, Jentsch D, Scholl MA et al. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 1991; 31 (5): 537–41.
10. Niethard FU, Gold MS, Solomon GS et al. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J Rheumatol 2005; 32 (12): 2384–92.
11. Zacher J, Burger KJ, Farber L et al. Topical diclofenac Emulgel versus oral ibuprofen in the treatment of active osteoarthritis of the finger joints (Heberden's and/or Bouchard's nodes). Double-blind, controlled, randomized study. Akt Rheumatol 2001; 26: 7–14.
12. Garcia Miranda R. Treatment of musculoskeletal injuries in athletes with a new topical antiphlogistic: Diethylammonium diclofenac. Double-blind comparative study. Compend.Invest.Clin.Latinoamer (MEX) 1987; 3: 9–24.
13. Diebschlag W. Diclofenac bei stumpf-traumatischen Sprunggelenkschwellungen. Fortschritte der Medizin 1986; 104: 437–440.
14. Magnette J, Kienzler JL, Alekxandrova I et al. The efficacy and safety of lowdose diclofenac sodium 0.1% gel for the symptomatic relief of pain and erythema associated with superficial natural sunburn. Eur J Dermatol 2004; 14 (4): 238–46.
15. Kienzler JL, Magnette J, Queille-Roussel C et al. Diclofenac-Na gel is effective in reducing the pain and inflammation associated with exposure to ultraviolet light – results of two clinical studies. Skin Pharmacol Physiol 2005; 18 (3): 144–52.
Авторы
G.Fotopoulos
Global Medical Affairs
Global Medical Affairs
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.